1. Home
  2. AUDC vs ACIU Comparison

AUDC vs ACIU Comparison

Compare AUDC & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

HOLD

Current Price

$9.12

Market Cap

245.9M

Sector

Utilities

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.86

Market Cap

288.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUDC
ACIU
Founded
1992
2003
Country
Israel
Switzerland
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.9M
288.0M
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
AUDC
ACIU
Price
$9.12
$2.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$12.50
$10.00
AVG Volume (30 Days)
109.8K
255.6K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
4.54%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.24
$706.75
Revenue Next Year
$2.18
$321.13
P/E Ratio
$23.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.95
$1.60
52 Week High
$11.48
$4.00

Technical Indicators

Market Signals
Indicator
AUDC
ACIU
Relative Strength Index (RSI) 56.71 46.57
Support Level $8.46 $2.58
Resistance Level $9.82 $2.99
Average True Range (ATR) 0.33 0.16
MACD 0.01 -0.00
Stochastic Oscillator 94.55 37.00

Price Performance

Historical Comparison
AUDC
ACIU

About AUDC AudioCodes Ltd.

AudioCodes Ltd provides voice communications solutions for enterprises, contact centers, and service providers, including voice infrastructure, cloud-based platforms, and Voice AI applications. Its AudioCodes Live Platform is a cloud-based service delivery platform that enables provisioning, management, and operation of voice and AI-based communication services, including PSTN connectivity and integration with platforms such as Microsoft Teams, Webex Calling, and Zoom Phone. The company's solutions are organized into three layers: voice infrastructure and devices, cloud-based platforms, and Voice AI applications for contact center and productivity use cases. It also offers management tools such as One Voice Operations Center (OVOC), Device Manager, and AudioCodes Routing Manager (ARM).

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: